Filing Details

Accession Number:
0001179110-18-009767
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2018-07-17 17:49:07
Reporting Period:
2018-07-13
Accepted Time:
2018-07-17 17:49:07
Original Submission Date:
2018-07-17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1260990 Gtx Inc GTXI Pharmaceutical Preparations (2834) 621715807
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1648010 C. Diane Young 175 Toyota Plaza
7Th Floor
Memphis TN 38103
Vp, Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-07-13 2,014 $14.92 47,985 No 4 F Direct
Common Stock Disposition 2018-07-16 2,049 $14.70 45,936 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Shares withheld by the issuer pursuant to the Rule 16b-3(c) exemption to satisfy tax withholding obligations arising out of the vesting of a portion of previously granted restricted stock units.
  2. Shares sold to satisfy tax withholding obligations arising out of the vesting of a portion of previously granted restricted stock units.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.43 to $14.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
  4. Due to clerical error, the Reporting Person is filing this amendment to correctly indicate the securities were disposed of rather than acquired as was shown in the previous filing on July 17, 2018. The amount of securities beneficially owned following the reported transaction in Table I, Box 5 remains correct.